Singapore, May 15, 2008: Germany’s Vetter Pharma-Fertigung has appointed Peter Soelkner in the management team.
His appointment is effective June 1 and he will be heading a number of divisions at the Ravensburg-based company, which specializes in the filling of prefilled injection systems.
His new tasks will include Global Key Account Management, Corporate Marketing, Supply Chain Management and Project Management. Soelkner will be joining the current Managing Directors Max Horn and Thomas Otto in handling company business.
Peter Soelkner has extensive experience with the international pharmaceutical and biotech industries. In his ten years of experience, Soelkner has worked with various companies.
His earlier assignment was as Vice President Global KAM at Stedim Biotech, USA. His tasks there included managing the successful merger of Sartorius and Stedim to form Sartorius Stedim Biotech.
Prior to his posting abroad, he was employed from 2003 to 2007 as Director of the Key Account Management at Vetter. He managed the implementation of the “End to End Supply Chain Organization” concept at Vetter, thus attaining an "Operational Excellence Class A" certification for the company within a record time of 11 months.
“Peter Soelkner is our candidate of choice," says Max Horn, Managing Director, Vetter Pharma-Fertigung. “He has the necessary experience in international management and a great deal of expertise in the pharma and biotech industries, plus he is already completely familiar with the structures and products of our company. This makes him the perfect man for us.”
| 
Comment on this article
